
Middlefield Canadian Income PCC: Director/PDMR Shareholding
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Middlefield Limited | |
2 | Reason for the notification | ||
a) | Position/status | Person closely associated with Dean Orrico, Director | |
b) | Initial notification /Amendment | Initial notification | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Middlefield Canadian Income PCC on behalf of Middlefield Canadian Income – GBP PC | |
b) | LEI | 2138007ENW3JEJXC8658 | |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument Identification code | Redeemable Participating Preference Shares ISIN GB00B15PV034 | |
b) | Nature of the transaction | Purchase | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
£1.21 | 50,000 | ||
d) | Aggregated information - Aggregated volume - Price | 50,000 £60,500.00 | |
e) | Date of the transaction | 7 May, 2025 | |
f) | Place of the transaction | London Stock Exchange XLON |
Persons closely associated with Mr Orrico hold in aggregate 220,000 Redeemable Participating Preference Shares, representing 0.21% of the Fund's issued share capital (excluding treasury shares).
Middlefield Limited is the Company's investment manager.
Enquiries:
JTC Fund Solutions (Jersey) Limited
Secretary
Tel.: 01534 700 000
Dean Orrico
President
Middlefield International Limited
Tel.: 01203 7094016
END OF ANNOUNCEMENT


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment